Abstract
Migration inhibitory factor (MIF) is known to exert significant pro-inflammatory effects and has the potential to override the anti-inflammatory action of glucocorticoids. In this study we have identified significant quantities of MIF in the alveolar airspaces of patients with acute respiratory distress syndrome (ARDS). We show in alveolar cells from patients with ARDS that MIF augments pro-inflammatory cytokine secretion (TNFα and IL-8), anti-MIF significantly attenuates TNFα and IL-8 secretion and MIF overrides, in a concentration-related fashion, the anti-inflammatory effects of glucocorticoids. These findings suggest that MIF may act as a mediator sustaining the pulmonary inflammatory response in ARDS and that an anti-MIF strategy may represent a novel therapeutic approach in inflammatory diseases such as ARDS.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Bloom, B.R. & Bennett, B. Mechanism of a reaction in vitro associated with delaye type hypersensitivity. Science 153, 80–82 (1966).
David, J. Delayed hypersensitivity in vitro: Its mediation by Cell free substances formed by lymphoid Cell-antigen interaction. Prac Natl. Acad. Sci. USA 56, 72–77 (1966).
Bernhagen, J. et al. MIF is a pituitary-derived cytokine that potentiates lethal endotox-aemia. Nature 365, 756–759 (1993).
Calandra, T., Bernhagen, J., Mitchell, R.A. & Bucala, R. The macrophage is an important and previously unrecognized source of macrophage migratory inhibitory factor. J. Exp. Med. 179, 1895–1901 (1994).
Bernhagen, J. et al. Purification, bioactivity, and secondary structure analysis of mouse and human macrophage migration inhibitory factor (MIF). Biochemistry 33, 14144–14155 (1994).
Nishino, T. et al. Localisation of macrophage migration inhibitory factor (MIF) to secretory granules within the corticotrophic and thyrotrophic Cells of the pituitary gland. Mol. Med. 1, 781–788 (1995).
Calandra, T. et al. MIF as a glucocorticoid-induced modulator of cytokin production. Nature 377, 68–71 (1995).
Warshawski, J., Sibbald, W.J., Driedger, A.A. & Cheung, H. Abnormal neutrophil-pulmonary interaction in the adult respiratory distress syndrome. Am. Rev. Resp. Dis. 133, 797–804 (1986).
Donnelly, S.C. et al. Plasma elastase in multiple trauma and the adult respiratory distress syndrome (ARDS). Am. J. Respir. Crit. Care. Med. 151, 1428–1433 (1995).
Donnelly, S.C. et al. Interleukin 8 (IL-8) and the development of the adult respiratory distress syndrome (ARDS) in at-risk patient groups. Lancet. 341, 643–647 (1993).
Suter, P.M. et al. High bronchoalveolar levels of tumor necrosis factor and its inhibitors, interleukin-1, interferon and elastase, in patients with adult respiratory distress syndrome after trauma, shock or sepsis. Am. Rev. Resp. Dis. 145, 1016–1022 (1992).
Rocker, G.M., Wiseman, M.S., Pearson, D. & Shale, D.J. Diagnostic criteria for adult respiratory distress syndrome: time for reappraisal. Lancet 1, 120–123 (1989).
Christner, P. et al. Collagenase in the lower respiratory tract of patients with the adult respiratory distress syndrome. Am. Rev. Resp. Dis. 131, 690–695 (1985).
Baldwin, S.R. et al. Oxidant activity in expired air of patients with adult respiratory distress syndrome. Lancet 1, 11–13 (1986).
Sekido, N. et al. Prevention of lung perfusion injury in rabbits by a monoclonal antibody against interleukin-8. Nature 365, 654–657 (1993).
Folkesson, H.G. et al. Acid aspiration induced lung injury in rabbits is mediated by in-terleukin-8-dependant mechanisms. J. Clin. Invest. 96 107–116 (1995).
Barnes, P.J., Greening, A.P. & Crompton, C.K. Clucocorticoid resistance in asthma. Am. J. Respir. & Crit. Care Med. 152, S125–S142 (1995).
Bernard, G.R. et al. High-dose corticosteroids in patients with the adult respiratory distress syndrome. N. Engl. J. Med. 317, 1365–1370 (1987).
Luce, J.M. et al. Ineffectiveness of high-dose methylprednisolone in preventing parenchymal lung injury and improving mortality in patients with septic shock. Am. Rev. Respir. Dis. 138, 62–68 (1988).
Meduri, G.M. et al. Corticosteroid rescue treatment of progressive fibro-proliferation in late ARDS. Chest 105, 1516–1527 (1994).
Ashbaugh, D.G., St Maier, R.V. Idiopathic pulmonary fibrosis in adult respiratory distress syndrome. Arch. Surg. 120, 530–535 (1990).
Hooper, R.G. & Kearl, R.A. Established ARDS treated with a sustained course of adrenocortical steroids. Chest 97, 138–143 (1990).
Bernard, G.R. et al. The American-European Consensus Conference on ARDS: Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am. J. Respir. Crit. Care Med. 149, 818–824 (1994).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Donnelly, S., Haslett, C., Reid, P. et al. Regulatory role for macrophage migration inhibitory factor in acute respiratory distress syndrome. Nat Med 3, 320–323 (1997). https://doi.org/10.1038/nm0397-320
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/nm0397-320
